Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

2015 Treatment Recommendation Updates for Psoriatic Arthritis Address Comorbidities, New Medications

Mary Beth Nierengarten  |  November 16, 2016

In May, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) published its recommendations for the treatment of psoriatic arthritis (PsA).1 The updated recommendations represent advances in drug development and availability since previous recommendations published in 2009, as well changes in treatment paradigms and the importance of associated aspects of the disease.2…

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:ClinicalcomorbiditiesdrugGroup for Research and Assessment of Psoriasis and Psoriatic ArthritisguidelineManagementMedicationPsoriasisPsoriatic Arthritisrecommendationtherapy

Not All Infectious Microorganisms Malign Human Immune System

Simon M. Helfgott, MD  |  November 16, 2016

Which came first? The infectious microorganism or a host’s immune resistance against it? Through the millennia, a raging battle has pitted the hordes of infectious agents surrounding us against, arguably, the most complex biologic structure ever created, the finely tuned human immune system. The stakes are high for both sides. For the infectious agent, an…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:autoimmunityDiseaseessential mixed cryoglobulinemiaHepatitis C virushuman microbiomeImmune SystemInfectionmicroorganism

Ocular Disease Monitoring Critical to Avoid Retinal Toxicity from Hydroxychloroquine

Megan L. Krause, MD, Vinicius Domingues, MD & Donald Miller, PharmD  |  November 16, 2016

Both due to its efficacy and favorable side effect profile when compared with alternative drugs for rheumatologic conditions, hydroxychloroquine is an important agent in rheumatologists’ armamentarium. However, one barrier to hydroxychloroquine use can be its effects on the eye (also see “Revised Retinopathy Screening Guidelines,”). Ocular side effects of hydroxychloroquine can include impact on the…

Filed under:Conditions Tagged with:eyeHYDROXYCHLOROQUINEocular diseaseophthalmalogistpatient careretinal toxicityRheumatic DiseaserheumatologistrisktherapyTreatmentvision

Rheumatology Fellowship Work in Ethiopia Reveals Gaps in Practical Management of Rheumatic Diseases

Mary Abraham, MD, MBA, with Frehyiwot Ayele, MD  |  November 16, 2016

The first month of my last year of rheumatology fellowship began in Addis Ababa, Ethiopia, at Black Lion Hospital, a tertiary university medical center, where I [Dr. Mary Abraham] started an Emory-sponsored global health rotation. Although a very different beginning to my fellowship year, my experiences at Black Lion reminded me of my passion to…

Filed under:Rheumatoid Arthritis Tagged with:Black Lion HospitalDr. Frehyiwot AyeleDr. Mary AbrahamEthiopiafellowshipInternationalpatient careresidentrheumatology

ACR President Dr. Joan Von Feldt Reflects on Her Year in Office, Advancing Rheumatology!

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  November 16, 2016

This has been a year of tremendous growth, change and achievement for the ACR, and I have been fortunate to lead the ACR in these endeavors. The ACR and ARHP, including the ACR Executive Committee, the ACR Board of Directors, standing and special committee chairs and hundreds of dedicated volunteers, have contributed to this growth…

Filed under:President's Perspective Tagged with:American College of Rheumatology (ACR)Dr. Joan Von Feldtofficepresidentrheumatology

Lateral Hip Pain: Could It Be Gluteal Tendinopathy?

Lara C. Pullen, PhD  |  November 14, 2016

Researchers recently found that physical tests that involve an active muscle contraction were most useful in identifying gluteal tendinopathy in patients with lateral hip pain. However, patients who were not palpably tender over the greater trochanter were unlikely to have GT detected during an MRI…

Filed under:ConditionsSoft Tissue Pain Tagged with:gluteal tendinopathyhiphip painMagnetic resonance imaging (MRI)MRITendinopathy

Second Biosimilar Equivalent to Adalimumab

Michele B. Kaufman, PharmD, BCGP  |  November 9, 2016

A recent study established the equivalency of BI 695501, a biosimilar, to its reference product, adalimumab, for treating patients with rheumatoid arthritis…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBI 695501BiosimilarsFDAFood and Drug AdministrationLabeling Changessafety warningtestosterone

Treating the Athlete: New Thoughts on How to Prevent & Treat Arthritis in Athletes & Raise Their Awareness

Karen Appold  |  November 4, 2016

All athletes—amateur and professional—should understand their risks for developing injury-related arthritis. Rheumatologists and other physicians at the Hospital for Special Surgery in New York take a rapid approach to treating athletes, often considering intense physical therapy, innovative treatments and surgery much sooner than for the average patient—all to keep joints healthy and enable athletes to play for as long as possible…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Exercise/physical therapyinjuryphysical fitnessPhysical Therapysecukinumab

Designate a Data Expert for Your Practice

Richard Quinn  |  October 21, 2016

With Medicare and insurers now incentivizing physicians for collecting and reporting data, rheumatologists need at least a minimum understanding of the gigabytes of information flowing through their practices. Actually, every medical practice should have at least one person with some informatics expertise, according to computer-programmer-turned-rheumatologist Jeffrey Curtis, MD, MS, MPH. “Physicians need to be more…

Filed under:Information TechnologyTechnologyTechnology Tagged with:data managementHealth Information Technologypatient dataRISERISE registryTechnology

Choose the Right EHR the 1st Time

Karen Appold  |  October 20, 2016

With so many electronic health record (EHR) systems on the market, it can be difficult to decide which one to choose. You may want to ask your peers for recommendations, visit practices that are using a system you’re contemplating and consider advice in trade journals. Jeffrey G. Lawson, MD, physician, Piedmont Arthritis Clinic, Greenville, S.C.,…

Filed under:EMRsPractice SupportProfessional Topics Tagged with:EHRElectronic health records

  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 126
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences